- Home
- GDDY vs TEVA Comparison
GDDY vs TEVA Comparison
Compare GDDY & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDDY | TEVA |
|---|---|---|
| Founded | 1997 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.0B | 30.2B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | GDDY | TEVA |
|---|---|---|
| Price | $125.88 | $31.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $187.00 | $31.00 |
| AVG Volume (30 Days) | 1.6M | ★ 10.4M |
| Earning Date | 10-30-2025 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.80 | 0.62 |
| Revenue | $4,869,800,000.00 | ★ $16,776,000,000.00 |
| Revenue This Year | $10.32 | $4.74 |
| Revenue Next Year | $6.84 | $0.48 |
| P/E Ratio | ★ $21.94 | $49.18 |
| Revenue Growth | ★ 8.68 | 0.02 |
| 52 Week Low | $121.94 | $12.47 |
| 52 Week High | $216.00 | $30.56 |
Technical Indicators
Market Signals| Indicator | GDDY | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 83.76 |
| Support Level | $123.70 | $28.00 |
| Resistance Level | $127.95 | $30.44 |
| Average True Range (ATR) | 2.45 | 0.69 |
| MACD | 0.16 | 0.01 |
| Stochastic Oscillator | 26.85 | 98.09 |
Price Performance
Historical ComparisonAbout GDDY GoDaddy Inc.
GoDaddy provides domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.